Form 4: Pulmonx Corp Director Glendon E. French III Acquires Shares Through Restricted Stock Units

Director Glendon E. French III of Pulmonx Corp acquired 15,216 shares of common stock through a grant of Restricted Stock Units.

Summary

• On June 3, 2024, Glendon E. French III, a director of Pulmonx Corp, acquired 15,216 shares of common stock.
• This acquisition was through a grant of Restricted Stock Units (RSUs).
• Following the transaction, French directly owns 1,131,974 shares of Pulmonx Corp.
• The RSUs vest on the earlier of June 3, 2025 (or the next business day if that is not a business day) or the date of the next Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing related to stock ownership changes. The acquisition of shares by a director is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director may signal confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting of the RSUs is tied to future dates.

Industry Context

This filing is a routine disclosure related to insider transactions and provides insight into the compensation structure for Pulmonx Corp's directors. It doesn't offer specific commentary on the broader medical device industry or competitive landscape.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates